Toby Sargeant has used new statistical techniques to trace the evolutionary development of the Plasmodium species of parasites and the relationship between different clades. [ + ]

Alan Cowman’s group from WEHI may have found a weakness in the armour of the malaria parasite – by harnessing P. falciparum’s key defence strategy, they plan to turn it against itself. [ + ]

Nobel Prize winner to speak at Australian conference next month [ + ]

Life sciences sector bounces back in Q1FY09, showing positive growth [ + ]

SCS licenses adult-to-stem cell conversion technology [ + ]

US company Natus is after NZ’s BrainZ [ + ]

AtCor wins supply contract for SphygmoCor [ + ]

USCOM improves paediatric septic shock management [ + ]

A new maternal blood test may be able to predict chromosomal abnormalities at 12 weeks' gestation.

BioGrid will enable researchers to share and aggregate data on diseases. They will be able to extract the de-identified data they need to test hypotheses using their own analytical tools.

Halcygen completes first required IND trial [ + ]

Nobel award for Institut Pasteur HIV researchers, Gallo snubbed [ + ]

WA pharmaceutical marketing company Helicon Group has come up with a very smart plan to penetrate the world’s most enticing market – China – by targeting its newly emerging middle class. [ + ]

Winning the 2008 NSW BioFirst Commercialisation award has come at exactly the right time for Special Phage Holdings, which has treated a patient in the clinic and is currently looking at a second round of private fundraising to develop its portfolio of bacteriophages [ + ]

Xceed and Metabolic trade PolyNovo Biomaterials [ + ]